PT-141 | 10mg
WHAT IS PT141?
PT141 is a peptide developed by Palatin Technologies and acts as an agonist of the melanocortin receptor MC1, using it to treat various sexual dysfunctions and other health issues.
Bremelanotide is the synthetic analogue of the melanocyte-stimulating hormone (α-MSH), which stimulates the production of melanin in the skin. PT141 was created as a remedy for sexual dysfunction and is used for the treatment of other medical problems as well.
PT141 acts as a stimulant on melanocyte receptors and xanthine receptors. This helps increase libido and sexual desire in both men and women. This peptide helps improve erectile function in men and aids in the treatment of various types of sexual dysfunction in women.
Research on Bremelanotide PT141 continues for its positive effects on depression, mental health, chronic pain, hormonal imbalance, and other health issues.
WHAT ARE THE BENEFITS OF PT141?
Bremelanotide PT-141 is a peptide that enhances sexual function in both women and men. The application of PT141 has the following benefits:
PT141 improves libido and increases sexual desire in both men and women.
PT141 improves erectile function in men and helps improve blood circulation in the genital area.
PT141 enhances sexual sensations and leads to a more pleasurable orgasm.
PT141 does not affect mental health and does not induce a feeling of euphoria.
PT141 is used in the treatment of various sexual dysfunctions in women and men, as an alternative to other medicinal products.
PT141 boosts confidence and self-assurance during sexual intercourse.
It does not produce any adverse effects on the body or the psyche of the recipient.
It is beneficial for female sexual dysfunction, enhancing experience and sexual desire.
PT141 positively affects post-traumatic stress disorder, reducing feelings of fear, anxiety, and restlessness.
PT141 peptide has a fast onset of action, and its effects can last for hours.
CLINICAL TRIALS OF PT141 AND THEIR RESULTS:
PT141 is used to support sexual function in men and women. Numerous clinical trials demonstrate its positive effect in treating sexual dysfunctions.
In a clinical trial conducted in 2000 by Dr. Hula Claude, women suffering from hypersexual disorder participated. The participants were divided into two groups, with the first group receiving PT141 and the second receiving a placebo. The results showed that women taking PT141 experienced a higher level of sexual desire and greater satisfaction with sexual activity.
In 2004, another clinical study involving 21 men with erectile dysfunction was conducted. The application of PT141 led to significantly higher levels of sexual stimulation, longer-lasting erections, and overall improvement in sexual function.
In 2010, a third study on the effects of PT141, published in the "Journal of Sexual Medicine," included 327 women suffering from hypersexual disorder. The application of PT-141 on the participants resulted in improved sexual satisfaction, desire, and activity.
PROPER ADMINISTRATION AND DOSAGE OF PT141:
PT141 (Bremelanotide) is a medication used to treat sexual dysfunctions in men and women, acting as a libido stimulant.
The dosage of PT141 may vary depending on the individual needs of the patient.
Typically, the initial dose is 0.4-0.7 mg of PT141. The expected effect occurs within 1 to 6 hours. Administration schedule: 8 units subcutaneously 7 hours before sexual contact, preferably in the evening, and an additional 5 units in the morning. The expected effect lasts for the next 30 hours. Another dosing schedule is 10-12 units a few hours before sexual contact. One unit corresponds to 50 micrograms.
POSSIBLE SIDE EFFECTS OF PT141:
PT141 is a medicinal product that has a positive effect on sexual dysfunctions in both men and women. Like any medicinal product, some side reactions may occur with its use. These are related to headaches, nausea, skin irritations, and increased blood pressure.
These side effects are mild and usually subside within a few days. Consultation with a specialist is recommended if any of these symptoms occur.
Adherence to the prescribed dosage and application instructions by a specialist is mandatory to avoid more serious side reactions.
WHAT IS PT141?
PT141 is a peptide developed by Palatin Technologies and acts as an agonist of the melanocortin receptor MC1, using it to treat various sexual dysfunctions and other health issues.
Bremelanotide is the synthetic analogue of the melanocyte-stimulating hormone (α-MSH), which stimulates the production of melanin in the skin. PT141 was created as a remedy for sexual dysfunction and is used for the treatment of other medical problems as well.
PT141 acts as a stimulant on melanocyte receptors and xanthine receptors. This helps increase libido and sexual desire in both men and women. This peptide helps improve erectile function in men and aids in the treatment of various types of sexual dysfunction in women.
Research on Bremelanotide PT141 continues for its positive effects on depression, mental health, chronic pain, hormonal imbalance, and other health issues.
WHAT ARE THE BENEFITS OF PT141?
Bremelanotide PT-141 is a peptide that enhances sexual function in both women and men. The application of PT141 has the following benefits:
PT141 improves libido and increases sexual desire in both men and women.
PT141 improves erectile function in men and helps improve blood circulation in the genital area.
PT141 enhances sexual sensations and leads to a more pleasurable orgasm.
PT141 does not affect mental health and does not induce a feeling of euphoria.
PT141 is used in the treatment of various sexual dysfunctions in women and men, as an alternative to other medicinal products.
PT141 boosts confidence and self-assurance during sexual intercourse.
It does not produce any adverse effects on the body or the psyche of the recipient.
It is beneficial for female sexual dysfunction, enhancing experience and sexual desire.
PT141 positively affects post-traumatic stress disorder, reducing feelings of fear, anxiety, and restlessness.
PT141 peptide has a fast onset of action, and its effects can last for hours.
CLINICAL TRIALS OF PT141 AND THEIR RESULTS:
PT141 is used to support sexual function in men and women. Numerous clinical trials demonstrate its positive effect in treating sexual dysfunctions.
In a clinical trial conducted in 2000 by Dr. Hula Claude, women suffering from hypersexual disorder participated. The participants were divided into two groups, with the first group receiving PT141 and the second receiving a placebo. The results showed that women taking PT141 experienced a higher level of sexual desire and greater satisfaction with sexual activity.
In 2004, another clinical study involving 21 men with erectile dysfunction was conducted. The application of PT141 led to significantly higher levels of sexual stimulation, longer-lasting erections, and overall improvement in sexual function.
In 2010, a third study on the effects of PT141, published in the "Journal of Sexual Medicine," included 327 women suffering from hypersexual disorder. The application of PT-141 on the participants resulted in improved sexual satisfaction, desire, and activity.
PROPER ADMINISTRATION AND DOSAGE OF PT141:
PT141 (Bremelanotide) is a medication used to treat sexual dysfunctions in men and women, acting as a libido stimulant.
The dosage of PT141 may vary depending on the individual needs of the patient.
Typically, the initial dose is 0.4-0.7 mg of PT141. The expected effect occurs within 1 to 6 hours. Administration schedule: 8 units subcutaneously 7 hours before sexual contact, preferably in the evening, and an additional 5 units in the morning. The expected effect lasts for the next 30 hours. Another dosing schedule is 10-12 units a few hours before sexual contact. One unit corresponds to 50 micrograms.
POSSIBLE SIDE EFFECTS OF PT141:
PT141 is a medicinal product that has a positive effect on sexual dysfunctions in both men and women. Like any medicinal product, some side reactions may occur with its use. These are related to headaches, nausea, skin irritations, and increased blood pressure.
These side effects are mild and usually subside within a few days. Consultation with a specialist is recommended if any of these symptoms occur.
Adherence to the prescribed dosage and application instructions by a specialist is mandatory to avoid more serious side reactions.
WHAT IS PT141?
PT141 is a peptide developed by Palatin Technologies and acts as an agonist of the melanocortin receptor MC1, using it to treat various sexual dysfunctions and other health issues.
Bremelanotide is the synthetic analogue of the melanocyte-stimulating hormone (α-MSH), which stimulates the production of melanin in the skin. PT141 was created as a remedy for sexual dysfunction and is used for the treatment of other medical problems as well.
PT141 acts as a stimulant on melanocyte receptors and xanthine receptors. This helps increase libido and sexual desire in both men and women. This peptide helps improve erectile function in men and aids in the treatment of various types of sexual dysfunction in women.
Research on Bremelanotide PT141 continues for its positive effects on depression, mental health, chronic pain, hormonal imbalance, and other health issues.
WHAT ARE THE BENEFITS OF PT141?
Bremelanotide PT-141 is a peptide that enhances sexual function in both women and men. The application of PT141 has the following benefits:
PT141 improves libido and increases sexual desire in both men and women.
PT141 improves erectile function in men and helps improve blood circulation in the genital area.
PT141 enhances sexual sensations and leads to a more pleasurable orgasm.
PT141 does not affect mental health and does not induce a feeling of euphoria.
PT141 is used in the treatment of various sexual dysfunctions in women and men, as an alternative to other medicinal products.
PT141 boosts confidence and self-assurance during sexual intercourse.
It does not produce any adverse effects on the body or the psyche of the recipient.
It is beneficial for female sexual dysfunction, enhancing experience and sexual desire.
PT141 positively affects post-traumatic stress disorder, reducing feelings of fear, anxiety, and restlessness.
PT141 peptide has a fast onset of action, and its effects can last for hours.
CLINICAL TRIALS OF PT141 AND THEIR RESULTS:
PT141 is used to support sexual function in men and women. Numerous clinical trials demonstrate its positive effect in treating sexual dysfunctions.
In a clinical trial conducted in 2000 by Dr. Hula Claude, women suffering from hypersexual disorder participated. The participants were divided into two groups, with the first group receiving PT141 and the second receiving a placebo. The results showed that women taking PT141 experienced a higher level of sexual desire and greater satisfaction with sexual activity.
In 2004, another clinical study involving 21 men with erectile dysfunction was conducted. The application of PT141 led to significantly higher levels of sexual stimulation, longer-lasting erections, and overall improvement in sexual function.
In 2010, a third study on the effects of PT141, published in the "Journal of Sexual Medicine," included 327 women suffering from hypersexual disorder. The application of PT-141 on the participants resulted in improved sexual satisfaction, desire, and activity.
PROPER ADMINISTRATION AND DOSAGE OF PT141:
PT141 (Bremelanotide) is a medication used to treat sexual dysfunctions in men and women, acting as a libido stimulant.
The dosage of PT141 may vary depending on the individual needs of the patient.
Typically, the initial dose is 0.4-0.7 mg of PT141. The expected effect occurs within 1 to 6 hours. Administration schedule: 8 units subcutaneously 7 hours before sexual contact, preferably in the evening, and an additional 5 units in the morning. The expected effect lasts for the next 30 hours. Another dosing schedule is 10-12 units a few hours before sexual contact. One unit corresponds to 50 micrograms.
POSSIBLE SIDE EFFECTS OF PT141:
PT141 is a medicinal product that has a positive effect on sexual dysfunctions in both men and women. Like any medicinal product, some side reactions may occur with its use. These are related to headaches, nausea, skin irritations, and increased blood pressure.
These side effects are mild and usually subside within a few days. Consultation with a specialist is recommended if any of these symptoms occur.
Adherence to the prescribed dosage and application instructions by a specialist is mandatory to avoid more serious side reactions.